SETDB2 antibody [N1], N-term

GeneTex

SETDB2 antibody [N1], N-term

9

ICC/IF: 1:100-1:2000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

ImmunoFluorescence, ImmunoCytoChemistry

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

Liquid

SETDB2

SET domain bifurcated histone lysine methyltransferase 2

C13orf4; chronic lymphocytic leukemia deletion region gene 8 protein; CLLD8; CLLL8; histone-lysine N-methyltransferase SETDB2; KMT1F; lysine N-methyltransferase 1F; SET domain bifurcated 2

Rabbit

IgG

Histone-lysine N-methyltransferase SETDB2

Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 (see MIM 601128) methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 [PubMed 12754510]).[supplied by OMIM]

Human

-20°C or -80°C,2°C to 8°C

12352203